Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Conflict of Interest Management

Posted on By

Standard Operating Procedure for Identifying and Managing Conflicts of Interest in Clinical Research

Purpose

This SOP outlines the procedures for identifying, assessing, and managing conflicts of interest (COI) in clinical trials and clinical studies. The goal is to ensure the integrity of research and protect participants by preventing or mitigating conflicts of interest.

Scope

This SOP applies to all personnel involved in clinical trials and clinical studies, including principal investigators, clinical research coordinators, study team members, and other relevant personnel.

Responsibilities

  • Principal Investigator (PI): Discloses and manages potential conflicts of interest and ensures compliance with COI policies.
  • Study Team Members: Disclose any potential conflicts of interest and adhere to COI management plans.
  • Institutional Review Board (IRB): Reviews COI disclosures and management plans to ensure research integrity and participant protection.
  • Research Administration: Provides guidance and oversight for COI disclosures and management plans and maintains records of COI declarations and resolutions.
See also  SOP for Participant Recruitment and Screening

Procedure

  • Identification of Conflicts of Interest:
    • Require all study personnel, including the PI, to disclose any financial or non-financial interests that could influence their involvement in the study.
    • Encourage disclosure of relationships with sponsors, vendors, or other entities that may present a conflict of interest.
    • Establish regular intervals for COI disclosures throughout the study period.
  • Assessment and Management of Conflicts of Interest:
    • Review COI disclosures to assess
the potential impact on study integrity and participant safety.
  • Develop and implement a COI management plan if potential conflicts are identified, which may include removing personnel from certain study activities or assigning oversight responsibilities.
  • Documentation and Reporting:
    • Document COI disclosures, assessments, and management plans for each study.
    • Report COI management plans to the IRB or other oversight bodies as required for review and approval.
    • Maintain records of COI management for auditing and compliance purposes.
  • Training and Education:
    • Provide training to study personnel on COI policies, including disclosure requirements and management strategies.
    • Offer ongoing education to ensure study personnel stay informed about COI regulations and best practices.
  • Abbreviations Used

    • SOP: Standard Operating Procedure
    • PI: Principal Investigator
    • COI: Conflict of Interest
    • IRB: Institutional Review Board

    Documents

    • COI disclosure forms
    • COI management plans
    • IRB reports and approvals
    • Training and education materials

    References

    • Institutional COI policies and procedures
    • Regulatory guidelines (e.g., FDA, EMA, ICH-GCP)

    SOP Version

    Version: 1.0

    See also  SOP for Safety Reporting to Ethics Committees and IRBs
    Clinical Studies Tags:Adverse event reporting, Clinical data management, Clinical data validation, Clinical research compliance, Clinical research coordination, Clinical site selection, clinical studies, clinical study, Clinical study protocols, Clinical trial management, Clinical trial monitoring, Clinical trial participants, Clinical trial procedures, Clinical trial SOPs, clinical trials, Conflict of interest management, Data collection methods, Data management SOPs, eCRF validation, Electronic record-keeping guidelines, Electronic systems validation, Ethics committee reporting, Investigator training protocols, Participant data privacy, Participant recruitment strategies, Pharmacovigilance protocols, Quality assurance practices, Regulatory compliance procedures, Risk management procedures, Safety monitoring procedures, Site selection criteria, Study protocol development

    Post navigation

    Previous Post: Clinical Studies: SOP for Emergency Preparedness and Response
    Next Post: SOP for Vendor and Third-Party Management

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version